Nordwand Advisors »

Eagle Pharmaceuticals shares owned by Nordwand Advisors

Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by Nordwand Advisors from 13F filings

Historical chart of Nordwand Advisors investment in Eagle Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eagle Pharmaceuticals held by Nordwand Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eagle Pharmaceuticals by Nordwand Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $523 100 5.23
2023-09-30 $1.6k 100 15.77
2023-06-30 $1.9k 100 19.44
2023-03-31 $2.8k 100 28.37